« Back
Home /
bdp9066

bdp9066

Item no.	V8872-250mg
Manufacturer	InvivoChem LLC
CASRN	2226507-04-4
Amount	250mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V8872CAS #:2226507-04-4Purity >=98% Description: BDP9066 is a novel, potent and selective MRCK (myotonic dystrophy-related Cdc42-binding kinase) inhibitor (IC50 of 64 nM for MRCKbeta in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKalpha/beta in house determinations, respectively.), reducing substrate phosphorylation. BDP9066 leads to morphological changes in cancer cells along with inhibition of their motility and invasive character. It has therapeutic effect on skin cancer by reducing substrate phosphorylation. References: Discoveryof Potent and Selective MRCK Inhibitors with Therapeutic Effect on SkinCancer. Cancer Res. 2018 Apr 15; 78(8):2096-2114.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250mg

available

Delivery expected until 9/6/2024

Express Delivery: Save 21 days

Compare

Add to wishlist

Recommend by mail